A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany

Multiple Sclerosis: Current Knowledge and Future Outlook

(2014) Christian P. Kamm et al.   EUROPEAN NEUROLOGY

Patient centered decision making: Use of conjoint analysis to determine risk–benefit trade-offs for preference sensitive treatment choices

(2014) Leslie Wilson et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies

(2014) Dean M. Wingerchuk et al.   MAYO CLINIC PROCEEDINGS

Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis

(2014) Kathrin S. Utz et al.   Therapeutic Advances in Neurological Disorders

Teriflunomide for the treatment of multiple sclerosis

(2013) Clemens Warnke et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

(2013) F. Reed Johnson et al.   VALUE IN HEALTH

A discrete choice experiment to determine patient preferences for injection devices in multiple sclerosis

(2013) S. L. Shingler et al.   JOURNAL OF MEDICAL ECONOMICS

New and emerging disease modifying therapies for multiple sclerosis

(2012) Shiv Saidha et al.   Annals of the New York Academy of Sciences

Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects

(2012) Martin S. Weber et al.   CURRENT PHARMACEUTICAL DESIGN

Interferon Beta and Glatiramer Acetate Therapy

(2012) Corey A. McGraw et al.   Neurotherapeutics

Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

(2011) John F.P. Bridges et al.   VALUE IN HEALTH

Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis

(2011) Rachel Halpern et al.   Patient Preference and Adherence

Health outcomes in economic evaluation: the QALY and utilities

(2010) S. J. Whitehead et al.   BRITISH MEDICAL BULLETIN

Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis

(2010) Stephanie C. Steinberg et al.   CLINICAL DRUG INVESTIGATION

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

(2010) V. Devonshire et al.   EUROPEAN JOURNAL OF NEUROLOGY

Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?

(2009) Alessandra Lugaresi   Expert Opinion on Drug Delivery

Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy

(2009) F. Reed Johnson et al.   JOURNAL OF NEUROLOGY

Factors that influence adherence with disease-modifying therapy in MS

(2009) Katherine Treadaway et al.   JOURNAL OF NEUROLOGY